Bank of America is bucking the downward trend in employer-sponsored coverage of GLP-1s for weight loss by maintaining its comparatively generous policies.

President Trump vowed better access to GLP-1 weight loss drugs for Medicaid recipients. But thus far only Indiana has publicly signed on with the administration’s demo.

The bags were distributed to at least 14 States and the FDA has warned of serious potential harm to patients including blood clots, allergic reactions and death.

The vaccine was not designed for the Bundibugyo strain causing the epidemic, but experts are hopeful that it may provide some protection while new vaccines are developed.

The therapy is a brand new targeted drug for the disease which experts have labelled as a substantial breakthrough following doubling of survival time in a trial.

Engineered regulatory T cells that recognize birch pollen reduced allergic airway inflammation in mice, hinting at a future cell therapy for severe allergies.

A two-antibody click-chemistry strategy improves targeted chemotherapy delivery to resistant HER2- and EGFR-positive tumors, boosting tumor control in mice.

New research suggests deep-sea vent metals powered early metabolism before enzymes existed, revealing how life may have begun making essential molecules on Earth.

Taiwan and Egypt show how universal screening, same-visit testing, affordable antivirals, and local care can put hepatitis C elimination within reach.

A new study shows cancer genes are not destiny: genetic background can shape whether inherited cancer risk becomes disease, when it begins, and how it develops.